Sponsor
GRUPO ESPAÑOL DE TUMORES NEUROENDOCRINOS (GETNE)
Principal Investigator
JAUME CAPDEVILA CASTILLON
Study details
Tumor type: NET
Stage: Advanced
Main Investigational Agent : ADC
Phase: II
Randomization: Non-randomized
Molecular details
Biomarker: Not applicable
Biomarker criteria: Not applicable
Prescreening: Not applicable
Additional study population requirements: Not applicable
Drug details
Arm A: enfortumab-vedotin
Links
Clinical Trials GOV (NCT identifier):
NL
EU Clinical Trials Register (eudraCT Identifier):
Not applicable
